Skip to search.
 All Ordinaries Down 2.01%

More On VLA.AX

Quotes

Charts

News & Info

  • Headlines
  • Company Events

Company

Analyst Coverage

Ownership

Financials

Viralytics Ltd (VLA.AX)

-ASX
0.63 Up 0.01(0.80%) 1 Sep 15:51
Add to Portfolio
Prev Close:0.63
Open:0.64
Bid:0.61
Ask:0.65
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.61 - 0.64
52wk Range:0.27 - 0.93
Volume:86,242
Avg Vol (3m):388,284
Market Cap:116.02M
P/E (ttm):N/A
EPS (ttm):-0.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Headlines

  • No Headlines available for VLA.AX at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):45.96
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-14) :N/A
Quarterly EPS Est (Dec-14) :-0.01
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Viralytics Limited, a biotechnology company, engages in developing oncolytic immunotherapy treatments for a range of cancers in Australia. Its lead investigational product is CAVATAK, a proprietary formulation of the common cold Coxsackievirus Typ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback